Immune Pharma (IMNP) Misses Q4 EPS by 13c

Immune Pharma (NASDAQ: IMNP) reported Q4 EPS of ($0.27), $0.13 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Immune Pharma (IMNP) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• CalPrivate Bank names Andra Frazier as chief credit officer
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance